Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
PIK-PD-1 cells in advanced hepatocellular carcinoma
NCT02632006Phase 2Unknown
- Sponsor
- Naval Medical University
- Start
- Sep 2015
- Primary completion
- Mar 2017
- Modality
- Antibody Conjugates, Cell Therapies, Engineered Antibody Formats
- Countries
- 1
01
Overview
Phase 2, randomised, open-label trial of PIK-PD-1 in hepatocellular carcinoma (HCC), sponsored by Naval Medical University. Status: unknown.
02
Drugs
PIK-PD-1
03
Conditions
hepatocellular carcinoma (HCC)
Beyond the preview
Go deeper on NCT02632006.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02632006.